Genetic Determinants of Fatty Acid Composition in Subcutaneous and Visceral Adipose Tissue
Obesity · 2025
DOI: 10.1002/oby.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2025. Verfasst von Altayeb Ahmed und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Natural Sciences, College of Health and Science, University of Lincoln, Joseph Banks Laboratories, Lincoln, UK. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, Fatty Acids, Subcutaneous Fat. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Calico Life Sciences LLC, Diabetes UK.
Abstract (Originalsprache)
Objective
Fatty acids in adipose tissue are key structural and metabolic regulators of cardiometabolic health, but the genetic architecture governing depot‐specific composition in subcutaneous (SAT) and visceral adipose tissue (VAT) is not well defined.
Methods
We used MRI‐derived estimates of fatty acid composition in SAT and VAT from 33,583 UK Biobank participants to perform genome‐wide association studies. Functional annotation, fine mapping, colocalization, and expression QTL analyses were conducted to prioritize likely causal variants and explore mechanisms.
Results
We identified six loci associated with adipose tissue fatty acid composition, including both shared ( PKD2L1 , INSIG1 ) and depot‐specific associations ( LEKR1 and KLF14 for SAT; CDCA2 for VAT). The strongest association, rs603424‐G (near PKD2L1 ), was linked to higher monounsaturated and polyunsaturated fatty acids, lower saturated fatty acids, and increased SCD1 expression in SAT and VAT, suggesting a role in desaturation and lipid remodeling. Several loci were linked to cardiometabolic outcomes including type 2 diabetes, hypertension, and cholelithiasis, with functional evidence supporting gene–diet interactions at the PKD2L1 locus.
Conclusions
Our findings uncover genetic determinants of human adipose tissue fatty acid composition, highlight depot‐specific regulation, and point to SCD1 as a potential metabolic regulator. These results deepen understanding of lipid metabolism and its links to cardiometabolic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Natural Sciences, College of Health and Science, University of Lincoln, Joseph Banks Laboratories, Lincoln, UK.
- School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
- Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK.
- Calico Life Sciences LLC, South San Francisco, California, USA.
ORCID-Profile: Altayeb Ahmed, Afreen Naz, Marjola Thanaj, E Louise Thomas
Förderung
- Calico Life Sciences LLC
- Diabetes UK
Zitieren
APA
Ahmed, A., Naz, A., Thanaj, M., Sorokin, E. P., Whitcher, B., Bell, J. D., Thomas, E. L., Cule, M., & Yaghootkar, H. (2025). Genetic Determinants of Fatty Acid Composition in Subcutaneous and Visceral Adipose Tissue. Obesity. https://doi.org/10.1002/oby.70045
Vancouver
Ahmed A, Naz A, Thanaj M, Sorokin EP, Whitcher B, Bell JD, et al. Genetic Determinants of Fatty Acid Composition in Subcutaneous and Visceral Adipose Tissue. Obesity. 2025. doi:10.1002/oby.70045
BibTeX
@article{Ahmed2025,
author = {Ahmed, Altayeb and Naz, Afreen and Thanaj, Marjola and Sorokin, Elena P and Whitcher, Brandon and Bell, Jimmy D and Thomas, E Louise and Cule, Madeleine and Yaghootkar, Hanieh},
title = {Genetic Determinants of Fatty Acid Composition in Subcutaneous and Visceral Adipose Tissue},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.70045}
}
EUVIMED